Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
C. Freire (Baltimore, United States of America), H. Pho (Baltimore, United States of America), L. Kim (Baltimore, United States of America), X. Wang (Washington, United States of America), J. Dyavanapalli (Washington, United States of America), S. Streeter (Baltimore, United States of America), T. Fleury-Curado (Baltimore, United States of America), D. Mendelowitz (Baltimore, United States of America), V. Polotsky (Baltimore, United States of America). Intranasal leptin prevents opioid-induced respiratory depression. 4735

Member's Comments

No comment yet.

Related content which might interest you: Ampakine therapy to alleviate opioid and anesthetic induced respiratory depression Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 Efficacy of intranasal corticosteroid therapy on lower respiratory tract responsiveness in children with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006 Clenbuterol antagonize the effect of chronic administration of steroid respiratory muscle in mice Source: Eur Respir J 2002; 20: Suppl. 38, 496s Year: 2002 Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients Source: ERJ Open Res, 6 (3) 00093-2020; 10.1183/23120541.00093-2020 Year: 2020 Oral steroids induce leptin and adiponectin in subjects with airway obstructive diseases Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 Exogenous surfactant in acute respiratory distress syndrome: more is better Source: Eur Respir J 2002; 19: 787-789 Year: 2002 Intracerebroventricular serotonin reduces the degree of acute hypoxic ventilatory depression in peripherally chemodenervated rabbits Source: Eur Respir J 2007; 30: Suppl. 51, 597s Year: 2007 Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS Source: Eur Respir J 2003; 22: 57S-64S Year: 2003 Investigating the safety of capsaicin cough challenge in severe asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 R411 treatment reduces asthma exacerbations and attenuates FEV1 fall following steroid withdrawal in moderate asthma Source: Eur Respir J 2005; 26: Suppl. 49, 252s Year: 2005 Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 24s Year: 2007 Effect of lidocaine and its delivery in chronic cough Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Treatment of chronic cough with morphine Source: Eur Respir J 2006; 28: Suppl. 50, 437s Year: 2006 Exogenous pulmonary surfactant combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome Source: Annual Congress 2007 - Lung recruitment Year: 2007 Corticosteroids in acute respiratory distress syndrome Source: Virtual Congress 2021 – Respiratory critical care Year: 2021 The non-glucocorticosteroid EPI-12323 attenuates acute allergen LAR and improves symptomotology in mild asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 220s Year: 2004 Hyperlactic acidosis as metabolic side-effect of albuterol and theophylline in acute severe asthma Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children Year: 2008 The impact of systemic corticosteroids on respiratory muscle function in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 505s Year: 2005 Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016 Year: 2017